Do not use Epirubicin Strides
- if you are allergic (hypersensitive) to epirubicin, similar medicines (called anthracyclines, see below) or any of the other ingredients of Epirubicin Strides;
- if you have been treated before with high doses of some other anti-cancer medicines including doxorubicin and daunorubicin which belong to the same group of drugs as Epirubicin Strides (called anthracyclines). They have similar side effects (including those effects on the heart);
- if you suffered or currently have heart problems;
- if you are breast feeding;
Strides Arcolab International Ltd. Epirubicin Strides 2 mg/ml solution for injection or infusion PILE – 2/14 July 2011
- if you have a low blood count;
- if you have a severe liver function disorder;
- if you suffer from an acute severe infection.
When administered intravesically (directly into the bladder), Epirubicin Strides should not be used if:
- the cancer has penetrated the bladder wall;
- you have an infection in your urine tract;
- you have pain or inflammation in your bladder;
- your doctor has problems inserting a catheter (tube) into your bladder;
- there is a large volume of urine left in your bladder after you attempt to empty it;
- if your urine contains blood;
- if you have a contracted bladder.
Take special care with Epirubicin Strides
- if you are elderly or a child, because of the higher risk of severe cardiac side effects. Your cardiac function will be checked before and after the treatment with epirubicin.
- if you have had problems with your heart in the past or if you are currently experiencing such problems. You should inform your doctor. The dose of epirubicin will have to be adjusted. Your doctor will regularly check if your heart is working properly.
- if you have previously been treated with products to fight cancer (such as with doxorubicin or daunorubicin or anthracenedion derivatives) or if you have had radiation, because the risk of severe cardiac side effects is greater. Inform your doctor because this is included in determining the total dose of epirubicin you will be administered.
- if you have a liver or kidney disorder. This may cause an increase in side effects. Both the kidney function and the liver function will be checked regularly and if needed the dose will be adjusted.
- if you desire to have children. Both men and women should use effective contraceptive measures both during and for 6 months after the treatment. Men are advised to request information about the possibility of storing sperm by means of freezing before the treatment.
- if you suffer from infections or bleedings. Epirubicin may affect the bone marrow. The number of white blood cells in your blood will be reduced, which makes you more susceptible to infections (leucopoenia). Bleedings can occur more easily (thrombocytopenia). These side effects are temporary in nature. The reduction of the number of white blood cells is greatest 10-14 days after the administration and usually returns to normal 21 days after the administration.
- if you have recently received or want to receive any vaccination.
- to check the level of uric acid in your blood. Your doctor will check this.
- to ensure the number of cells in your blood does not drop too low. Your doctor will regularly check this.
- if you are experiencing severe inflammation or ulcers in your mouth.
- if you have received or are receiving radiotherapy to the chest area.
- if you get a burning feeling at the site of the administration. This could indicate that epirubicin is leaking outside the blood vessel. Warn your doctor about this.
Please consult your doctor if one of the above mentioned warnings is applicable to you, or has been applicable to you in the past.
Strides Arcolab International Ltd. Epirubicin Strides 2 mg/ml solution for injection or infusion PILE – 3/14 July 2011
Using other medicines
Attention: the following remarks may also be applicable to the recent use of medicinal products or their use in the near future.
The medicines mentioned in this section may be known to you under a different name, often the brand name. In this section only the active ingredient(s) of the medicinal product is mentioned, not the brand name! Therefore always carefully read on the package or in the patient leaflet what the active ingredient is of the medicines you are using.
An interaction means that (medicinal) products that are used together can influence each other's effect and/ or side effect. An interaction can occur with the concomitant use of this solution and:
- the harmfulness to the heart can increase with prior or concomitant administration of other products related to epirubicin, so-called anthracyclines (for instance the cancer fighting medicines mitomycin-C, dacarbazine, dactinomycin and cyclophosphamide)or other medicines that may affect the heart (for instance the cancer fighting medicines 5-fluorouracil, cyclophosphaminde, cisplatin, taxanes). Extra monitoring of the heart is then necessary.
- epirubicin can increase the effect of radiation and even after quite some time after the radiation it can cause serious side effects in the irradiated area.
-
rifampicin (product used for the treatment of tuberculosis) and barbiturates (products that are used for insomnia or epilepsy, such as for instance phenobarbital); these products decrease the amount of epirubicin in the blood, which could lead to a reduced effect of epirubicin.
-
paclitaxel and docetaxel (products that are used for some cancers); when paclitaxel is administered before epirubicin or docetaxel is administered immediately after epirubicin, the amount of epirubicin in the blood is increased, which could lead to an increase of the side effects.
-
dexverapamil (a product that is used to treat some cardiac disorders); when used together with epirubicin it may have a negative effect on bone marrow.
-
interferon a2b (a product used in some cancers and lymphomas and some forms of hepatitis).
-
quinine (a product used for treatment of malaria and for leg cramps); quinine may speed up the distribution of epirubicin into the body, which may have a negative effect on the red blood cells.
-
dexrazoxane (a product sometimes used with doxorubicin to reduce the risk of heart problems); the time that epirubicin is present in the body may be decreased, which could lead to decreased effect of epirubicin.
-
cimetidine (a product to reduce the acid in your stomach); the amount of epirubicin in the blood is increased, which could lead to an increase of the side effects.
- previous or concomitant treatment with other products which influence the bone marrow (for instance other products to treat cancer, sulfonamide, chloramphenicol, diphenylhydantoin, amidopyrine-derivate, products against certain virus); the formation of blood cells can be disturbed.
-
products that cause heart failure.
-
products that influence the liver function; the degradation of epirubicin by the liver may be influenced, which may cause a reduced effect of epirubicin or an increase of the side effects.
-
live vaccines; there is risk of fatal disease therefore this combination is not recommended.
Strides Arcolab International Ltd. Epirubicin Strides 2 mg/ml solution for injection or infusion PILE – 4/14 July 2011
-
cyclosporine (a product that suppresses the immune system); the immune system may be suppressed to much.
Please tell your doctor or pharmacist if you are using or have recently used any other medicines, including medicines obtained without a prescription.
Using Epirubicin Strides with food and drink
You should not drink within 12 hours before application when epirubicine will be administered in the bladder.
Pregnancy and breast-feeding
Pregnancy
Medicines to fight cancer are only administered during pregnancy in extreme cases. The benefits for the mother must be weighed against the possible danger to the unborn child. In animal studies epirubicin proved to be harmful to the unborn child and can cause deformities. Both men and women should use good contraceptive measures (pill, condom) both during and for 6 months after the use of this medicine to prevent pregnancy.
You should also prevent pregnancy if you partner is treated with epirubicin.
If pregnancy occurs during treatment with epirubicin, genetic counselling is recommended.
Men who wish to father children in the future should seek advice about freezing sperm before treatment with epirubicin is started.
Breast feeding
It is not known whether epirubicin is excreted in the breast milk. You should discontinue breast-feeding during treatment with Epirubicin Strides.
Ask your doctor or pharmacist for advice before taking any medicine.
Driving and using machines
Because many people get very nauseous or have to vomit during the treatment, driving and using machines is not recommended.
Important information about some of the ingredients of Epirubicin Strides
This medicinal product contains 3.5 mg sodium per ml solution for injection or infusion. To be taken into consideration by patients on a controlled sodium diet.